Parallax Volatility Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-37,300
Closed -$4.31M 2363
2020
Q4
$4.31M Sell
37,300
-25,000
-40% -$2.8M ﹤0.01% 991
2020
Q3
$6.06M Buy
62,300
+34,400
+123% +$3.96M ﹤0.01% 1221
2020
Q2
$3.43M Buy
27,900
+20,400
+272% +$2.31M ﹤0.01% 1239
2020
Q1
$661K Buy
7,500
+5,600
+295% +$593K ﹤0.01% 1616
2019
Q4
$197K Sell
1,900
-50,600
-96% -$5.67M ﹤0.01% 2011
2019
Q3
$6.04M Buy
+52,500
New +$7.97M 0.01% 748
2019
Q2
Sell
-55,300
Closed -$9.32M 4085
2019
Q1
$9.32M Buy
55,300
+40,100
+264% +$5.97M 0.01% 502
2018
Q4
$1.48M Buy
+15,200
New +$1.99M ﹤0.01% 1177
2017
Q1
Sell
-88,000
Closed -$9.83M 4951
2016
Q4
$9.83M Buy
88,000
+56,000
+175% +$6.74M 0.02% 435
2016
Q3
$4.25M Buy
32,000
+22,000
+220% +$2.1M 0.01% 734
2016
Q2
$916K Buy
+10,000
New +$842K ﹤0.01% 1224
2016
Q1
Sell
-68,700
Closed -$4.77M 4023
2015
Q4
$4.77M Buy
+68,700
New +$5.6M 0.01% 697

Other funds holding GWPH

Parallax Volatility Advisers's GWPH Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 1,688 shares — an estimated $195K sold.

Parallax Volatility Advisers first reported a position in GWPH in Q4 2015 and held it in 13 quarters. The position peaked at $1.2M in Q3 2018. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,688 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $195K.
  • Parallax Volatility Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 13 quarters.
  • Parallax Volatility Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.2M in Q3 2018.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.